human epithelial lung cell line a549 (ATCC)
ATCC is a verified supplier
ATCC manufactures this product
Structured Review
Human Epithelial Lung Cell Line A549, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human epithelial lung cell line a549/product/ATCC
Average 99 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Nebulized Hybrid Nanoarchaeosomes: Anti-Inflammatory Activity, Anti-Microbial Activity and Cytotoxicity on A549 Cells"
Article Title: Nebulized Hybrid Nanoarchaeosomes: Anti-Inflammatory Activity, Anti-Microbial Activity and Cytotoxicity on A549 Cells
Journal: International Journal of Molecular Sciences
doi: 10.3390/ijms26010392
Figure Legend Snippet: IC 50 values of formulations on A549 cells.
Techniques Used:
Figure Legend Snippet: A549 cell viability after 72 h when treated with ( A ) BSs and ( B ) hybrid-nanoARCs. Statistical significance compared with medium control was determined using a Kruskal– Wallis non-parametric test followed by Dunn’s multiple comparisons, * p < 0.05, ** p < 0.01; **** p < 0.0001.
Techniques Used: Control
Figure Legend Snippet: A549 cell viability after 72 h when treated with nebulized BSs and BS + BS-nanoARCs. Statistical significance compared with medium control was determined using a Kruskal– Wallis non-parametric test followed by Dunn’s multiple comparisons, ** p < 0.01; **** p < 0.0001.
Techniques Used: Control
Figure Legend Snippet: Stability upon storage: ( A1 ) plasmonic peak and ( A2 ) size of BSs. A549 cell viability after treatment with stored ( B ) BSs and ( C ) [BS + BS-nanoARCs] (50 μg PL/mL, 12.5–25 μg total Ag/mL). Statistical significance compared with medium control was determined using a Kruskal–Wallis non-parametric test followed by Dunn’s multiple comparisons, ** p < 0.01; *** p < 0.001; **** p < 0.0001.
Techniques Used: Control